Open AccessGenetic and epigenetic bases of prostate tumor cell radioresistance
Author(s) -
Denis S. Kutilin
Publication year - 2021
Publication title -
klinicka onkologie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.204
H-Index - 13
eISSN - 1802-5307
pISSN - 0862-495X
DOI - 10.48095/ccko2021220
Subject(s) - radioresistance , cancer research , epigenetics , microrna , prostate cancer , biology , copy number variation , cancer , gene , genetics , cell culture , genome
Radiation therapy plays a leading role in the treatment of prostate cancer, but the emergence of radioresistant forms of this disease dictates the need for a personalized ap-proach based on the data from genetic and epigenetic markers. Such markers include the copy number variation as well as gene and microRNA expression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom